Nicotine Patch Bioequivalence Study

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the relative bioavailability of nicotine following single application of a new transdermal formulation to that of a reference formulation.

4 single 24hour applications separated by 48hour intervals.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label

Related Conditions & MeSH terms

Healthy Smokers

Clinical Trial Details

NCT number	NCT01658202
Study type	Interventional
Source	Pierre Fabre Medicament
Contact
Status	Completed
Phase	Phase 1
Start date	August 2012
Completion date	September 2012

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT00159302` - Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
Completed	`NCT03728530` - Effect Of Deep Breathing Exercises In Smokers	N/A
Completed	`NCT02089308` - Nicotine Patch - Bioequivalence Study	Phase 1
Completed	`NCT01574898` - Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations	Phase 1
Completed	`NCT01658215` - Nicotine Patch - Multidose Bioequivalence Study	Phase 1
Terminated	`NCT00753870` - Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers	Phase 1
Completed	`NCT01188239` - A Structured Protocol to Evaluate Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette)	N/A
Completed	`NCT01194583` - Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges	N/A
Completed	`NCT01164072` - Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette)	N/A